• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Cervical Cancer Treatment Market

Cervical Cancer Treatment Market: by Type (Squamous Cell Carcinomas, Adenocarcinomas, Adenosquamous Carcinomas), Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy), End-User (Cancer Care Centers) – Global Forecast Till 2025


Market Synopsis:
Over the last decade, there has been a significant increase in the prevalence of cancer. According to the World Health Organization (WHO), cancer is the second leading cause of death globally. Nearly 1 in every 6 death occurs due to cancer. In 2015, cancer was responsible for 8.8 million deaths. Cervical cancer is the fourth most common cancer in females. The uncontrolled growth of cells in the cervical region of a uterus is called cervical cancer. Strains of Human Papillomavirus (HPV), generally a sexually transmitted antigen, are the general cause of cervical cancer. The disease begins when healthy cells acquire mutation leading to the uncontrolled growth of cells. These cells form a tumor which invades the nearby tissues. Cervical cancer is common in low and middle-income countries.

The major driver of cervical cancer treatment market is increasing in the prevalence of cervical cancer and growing awareness of the treatment of cervical cancer in women. As per WHO, cervical cancer accounts for 3.7% of all the cancers. In 2012, 528,000 women were diagnosed with cervical cancer. Unprotected sexual contact and multiple pregnancies increase the chance of cervical cancer. Moreover, the growing trend of consumption of alcohol and tobacco products at a young age is adding to the patient pool of cervical cancer.

However, the expensive devices used in the treatment of cancer & high expertise required adds to the high cost of treatment. Furthermore, side effects associated with the medicines & therapies used in treatment are the challenges for the growth of the market.

The limited number of treatment and medicines available creates an opportunity for key players of the market to introduce more cost-effective methods to cure cancer. Government and private players are investing a huge amount in research and development to improve cancer treatment methods which are expected to fuel the market in near future. 

Regional Analysis:
Globally, the cervical cancer treatment market is segmented into four regions; North America, Europe, Asia Pacific and Latin America, Middle East & Africa (LAMEA).

North America is expected to hold the major share in the market during the forecast period, owing to their huge patient pool. According to the National Cancer Institute, in 2015, there were an estimated 257,524 women living with cervical cancer in the United States. The region also has advanced technology for the treatment of cancer. Moreover, the prevalence of alcohol consumption and smoking are high in the region. According to data from Centers for Disease Control and Prevention (CDC), more than 15 in every 100 U.S adults smoke cigarettes.

European region holds a notable share of cervical cancer treatment market. This is attributed to their advancement in technology and growing cases of cervical cancer in the region. Unprotected sexual contact is prevalent in the region. Additionally, the favorable reimbursement policy and presence of key players in the region are driving the market growth.

During the forecast period, Asia Pacific region is predicted to show the fastest growth in cervical cancer treatment market. The growing geriatric population and increasing prevalence of cervical cancer in the region are the major drivers of the market. According to the WHO, among total cancer mortality in India, 20.7% is of cervix and uterus. The medical facilities of the region are not technically advanced, this creates the opportunity for market players to introduce advanced equipment in the region.

LAMEA region is expected to show slow growth in the market during the forecast period owing to their underdeveloped economies and lack of medical facilities. Among LAMEA, Middle East region should have the fastest growth as the healthcare facilities are improving in the region. However the area has huge potential, the patient pool is huge in LAMEA region. As per the WHO data, the cancer mortality of females in South Africa is 20,600 out of this 16.9% is attributed to cervix and uteri.

Key players:
Novartis AG, Genentech USA, AstraZeneca plc, Eli Lilly and Company, Pfizer Inc., Allergan, Bristol-Myers Squibb Company, Actavis Pharma Company, Seimens Healthcare, QIAGEN and GlaxoSmithKline plc. are the key players working in global cervical cancer therapeutics.

Recently, Siemens Healthineers Company expanded its comprehensive sexually transmitted infections portfolio by adding an array of human papillomavirus (HPV) tests. 
In 2011, Epigenomics AG the cancer molecular diagnostics company, and QIAGEN announced that the companies have entered into an option agreement allowing QIAGEN to develop and, should QIAGEN exercise the option, commercialize a colorectal cancer blood test.

Global Market Segmentation:
By Type 

  • Squamous Cell Carcinomas
  • Adenocarcinomas
  • Adenosquamous Carcinomas

By Treatment

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Targeted Therapy
  • Others 

By End User

  • Hospitals 
  • Cancer care centers
  • Research institutes 
  • Others 

By region

  • North America 
    • U.S
    • Canada 
    • Mexico 
  • Europe
    • U.K
    • Germany 
    • France 
    • Italy 
    • Spain 
    • Rest of Europe 
  • Asia Pacific
    • China 
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific  
  • LAMEA
    • Brazil
    • UAE
    • Saudi Africa 
    • South Africa 
    • Rest of LAMEA

									

	

Related Reports

Global Wearable Blood Glucose Monitoring Systems Market Insights, Forecast to 2025

In 2017, the global Wearable Blood Glucose Monitoring Systems market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to ...read more

Global Voglibose Market Insights, Forecast to 2025

In 2017, the global Voglibose market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the ...read more

Global Vibrating Mesh Nebulizers Market Insights, Forecast to 2025

In 2017, the global Vibrating Mesh Nebulizers market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, ...read more

Global Veterinary Parasiticides Market Insights, Forecast to 2025

In 2017, the global Veterinary Parasiticides market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, ...read more

Global Veterinary Nutritional Feed Additives Market Insights, Forecast to 2025

In 2017, the global Veterinary Nutritional Feed Additives market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to defi ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.